PubRank
Search
About
McClellan M Walther
Author PubWeight™ 55.38
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Biochemical diagnosis of pheochromocytoma: which test is best?
JAMA
2002
4.84
2
The genetic basis of cancer of the kidney.
J Urol
2003
3.45
3
Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome.
Am J Hum Genet
2005
3.26
4
Renal tumors in the Birt-Hogg-Dubé syndrome.
Am J Surg Pathol
2002
3.06
5
Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.
Am J Hum Genet
2003
2.88
6
High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors.
J Natl Cancer Inst
2005
2.70
7
Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome.
J Urol
2005
2.33
8
The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease.
J Urol
2004
2.32
9
Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.
Hum Mutat
2004
1.78
10
Percutaneous radio frequency ablation of small renal tumors: initial results.
J Urol
2002
1.74
11
Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.
J Clin Endocrinol Metab
2003
1.70
12
Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.
Proc Natl Acad Sci U S A
2003
1.53
13
Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
Clin Chem
2005
1.52
14
Genetic basis of cancer of the kidney: disease-specific approaches to therapy.
Clin Cancer Res
2004
1.45
15
Thermal protection during percutaneous thermal ablation of renal cell carcinoma.
J Vasc Interv Radiol
2004
1.42
16
Percutaneous tumor ablation with radiofrequency.
Cancer
2002
1.31
17
Hereditary renal cancers.
Radiology
2003
1.31
18
Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.
J Urol
2004
1.20
19
Partial adrenalectomy: the National Cancer Institute experience.
Urology
2005
1.12
20
The genetic basis of cancer of kidney cancer: implications for gene-specific clinical management.
BJU Int
2005
0.98
21
Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison.
Radiology
2002
0.98
22
Management of von Hippel-Lindau-associated kidney cancer.
Nat Clin Pract Urol
2005
0.95
23
Intraoperative ultrasound aids in dissection during laparoscopic partial adrenalectomy.
J Urol
2002
0.93
24
Laparoscopic management of extra-adrenal pheochromocytoma.
J Urol
2004
0.93
25
Assessment of risk for intra-abdominal adhesions at laparoscopy for urological tumors.
J Urol
2002
0.91
26
Parenchymal sparing surgery for central renal tumors in patients with hereditary renal cancers.
J Urol
2004
0.90
27
Utility of plasma free metanephrines for detecting childhood pheochromocytoma.
J Clin Endocrinol Metab
2002
0.90
28
Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.
Endocr Pathol
2002
0.87
29
Diagnostic localization of malignant bladder pheochromocytoma using 6-18F fluorodopamine positron emission tomography.
J Urol
2003
0.85
30
Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
J Clin Endocrinol Metab
2005
0.84
31
Radiofrequency ablation of cancer.
Cardiovasc Intervent Radiol
2004
0.83
32
Surgical management of multi-organ visceral tumors in patients with von Hippel-Lindau disease: a single stage approach.
J Urol
2003
0.83
33
Surgical management of lumbosacral nerve root hemangioblastomas in von Hippel-Lindau syndrome.
J Neurosurg
2003
0.83
34
A phase I study of intravesical suramin for the treatment of superficial transitional cell carcinoma of the bladder.
J Urol
2003
0.82
35
Risk factors for skin breakdown after renal and adrenal surgery.
Urology
2004
0.78
36
A novel laparoscopic specimen entrapment device to facilitate morcellation of large renal tumors.
Urology
2002
0.77
37
Laparoscopic radical nephrectomy for advanced kidney cancer.
Curr Urol Rep
2002
0.76
38
Hereditary kidney cancer.
Urol Clin North Am
2003
0.76
39
Surgical images: Soft tissue laparoscopic resection of a renal hilar pheochromocytoma.
Can J Surg
2004
0.75
40
Metastatic renal cell carcinoma to contralateral ureter presenting as acute obstructive renal failure after radical nephrectomy.
Urology
2005
0.75
41
Transperitoneal laparoscopic radical nephrectomy for bulky renal tumors.
Can J Urol
2002
0.75
42
Bilateral testicular adrenal rests after bilateral adrenalectomies in a cushingoid patient with von Hippel-Lindau disease.
Urology
2004
0.75
43
Specimen morcellation after laparoscopic radical nephrectomy: confirmation of histologic diagnosis using needle biopsy.
J Endourol
2002
0.75
44
Update on minimally invasive approaches to kidney tumors.
Curr Urol Rep
2004
0.75
45
Intentional resection of the diaphragm during cytoreductive laparoscopic radical nephrectomy.
J Urol
2002
0.75